ARCT vs. CBAT

Last updated Jul 14, 2026

ARCT (Arcturus Therapeutics Holdings Inc.) and CBAT (CBAK Energy Technology, Inc.) are both stocks. ARCT operates in Biotechnology (Healthcare), while CBAT operates in Electrical Equipment & Parts (Industrials). At a 0.02 correlation, their price movements are largely independent.

Performance

ARCT vs. CBAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcturus Therapeutics Holdings Inc. (ARCT) and CBAK Energy Technology, Inc. (CBAT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ARCT

• 1D: -3.73%
• 1M: -3.73%
• 6M: -10.89%
• YTD: 9.46%
• 1Y: -51.31%
• 3Y*: -42.58%
• 5Y*: -24.79%
• 10Y*: —

CBAT

• 1D: -1.42%
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARCT vs. CBAT - Yearly Performance Comparison

	2026 (YTD)
ARCT Arcturus Therapeutics Holdings Inc.	-1.61%
CBAT CBAK Energy Technology, Inc.	-13.79%

Correlation

The correlation between ARCT and CBAT is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jun 30, 2026	0.02

Fundamentals

Market Cap ARCT : $190.72M CBAT : $44.32M
EPS ARCT : -$1.80 CBAT : -$0.10
PS Ratio ARCT : 3.97 CBAT : 0.23
PB Ratio ARCT : 1.00 CBAT : 0.00
Total Revenue (TTM) ARCT : $46.80M CBAT : $195.19M
Gross Profit (TTM) ARCT : $40.72M CBAT : $18.42M
EBITDA (TTM) ARCT : -$84.61M CBAT : -$18.44M

Return for Risk

ARCT vs. CBAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARCT

ARCT Risk / Return Rank: 23
ARCT Sharpe Ratio Rank: 19
ARCT Sortino Ratio Rank: 25
ARCT Omega Ratio Rank: 24
ARCT Calmar Ratio Rank: 18
ARCT Martin Ratio Rank: 26

CBAT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARCT vs. CBAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcturus Therapeutics Holdings Inc. (ARCT) and CBAK Energy Technology, Inc. (CBAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ARCT	CBAT	Difference
Sharpe ratio: Return per unit of total volatility	-0.56	—	—
Sortino ratio: Return per unit of downside risk	-0.36	—	—
Omega ratio: Gain probability vs. loss probability	0.95	—	—
Calmar ratio: Return relative to maximum drawdown	-0.69	—	—
Martin ratio: Return relative to average drawdown	-0.90	—	—

Drawdowns

ARCT vs. CBAT - Drawdown Comparison

The maximum ARCT drawdown since its inception was -95.23%, which is greater than CBAT's maximum drawdown of -17.42%. Use the drawdown chart below to compare losses from any high point for ARCT and CBAT.

Drawdown Indicators

	ARCT	CBAT	Difference
Max Drawdown Largest peak-to-trough decline	-95.23%	-17.42%	-77.81%
Max Drawdown (1Y) Largest decline over 1 year	-74.53%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-86.71%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-89.87%	—	—
Current Drawdown Current decline from peak	-94.57%	-17.42%	-77.15%
Average Drawdown Average peak-to-trough decline	-73.29%	-10.35%	-62.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	57.22%	—	—

Volatility

Volatility by Period

	ARCT	CBAT	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.41%	—	—
Volatility (6M) Calculated over the trailing 6-month period	40.17%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	91.90%	71.91%	+19.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	91.74%	71.91%	+19.83%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	101.63%	71.91%	+29.72%

Dividends

ARCT vs. CBAT - Dividend Comparison

Neither ARCT nor CBAT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ARCT and CBAT in my portfolio?

ARCT and CBAT have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.